Loading clinical trials...
Loading clinical trials...
The objective of the study is to investigate the effect of interventional program in improving the quality of life for individuals with chronic schizophrenia The design of the study will be an interve...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Psychiatric Hospital of the Cross
NCT07441928 · Smoking Cessation, Schizophenia Disorder
NCT06865937 · Schizophenia Disorder, Schizoaffective Disorder
NCT06831435 · Depression, Bipolar Affective Disorder, and more
NCT07314190 · Alzheimer Disease, Dementia With Lewy Bodies (DLB), and more
NCT06883734 · Schizophenia Disorder
Psychiatric Hospital of the Cross
Beirut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions